<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: journal of immunology</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Discovery shows fat triggers rheumatoid arthritis</title>
   	 <description>Scientists have discovered that fat cells in the knee secrete a protein linked to arthritis, a finding that paves the way for new gene therapies that could offer relief and mobility to millions worldwide.</description>
     <link>http://medicalxpress.com/news/2013-05-discovery-fat-triggers-rheumatoid-arthritis.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Wed, 08 May 2013 08:42:27 EST</pubDate>
	 <guid isPermaLink="false">news287221341</guid>
	 
</item>
<item>
     <title>Researchers identify a promising target for multiple sclerosis treatments</title>
   	 <description>A team of basic and clinical scientists led by the University of Montreal Hospital Research Centre's (CRCHUM) Dr. Nathalie Arbour has opened the door to significantly improved treatments for the symptoms of Multiple Sclerosis (MS). In a study selected as among the top 10% most interesting articles published in the Journal of Immunology, the team identifies the elevated presence in MS patients of a type of white blood cell (CD4 T cell) that expresses NKG2C, a highly-toxic molecule harmful to brain tissues.</description>
     <link>http://medicalxpress.com/news/2013-03-multiple-sclerosis-treatments.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 19 Mar 2013 13:22:48 EST</pubDate>
	 <guid isPermaLink="false">news282918158</guid>
	 
</item>
<item>
     <title>Mechanisms regulating inflammation associated with type 2 diabetes, cancer identified</title>
   	 <description>A study led by researchers at Boston University School of Medicine (BUSM) has identified epigenetic mechanisms that connect a variety of diseases associated with inflammation. Utilizing molecular analyses of gene expression in macrophages, which are cells largely responsible for inflammation, researchers have shown that inhibiting a defined group of proteins could help decrease the inflammatory response associated with diseases such as obesity, type 2 diabetes, cancer and sepsis.</description>
     <link>http://medicalxpress.com/news/2013-03-mechanisms-inflammation-diabetes-cancer.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 01 Mar 2013 11:21:16 EST</pubDate>
	 <guid isPermaLink="false">news281359263</guid>
	 
</item>
<item>
     <title>Molecular basis identified for tissue specific immune regulation in the eye and kidney</title>
   	 <description>Scientists at The University of Manchester have made important advances in understanding why our immune system can attack our own tissues resulting in eye and kidney diseases. It is hoped the research will pave the way for the development of new treatments for the eye condition age-related macular degeneration (AMD) and the kidney condition atypical Haemolytic Uremic Syndrome (aHUS).</description>
     <link>http://medicalxpress.com/news/2013-02-molecular-basis-tissue-specific-immune.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 20 Feb 2013 07:52:05 EST</pubDate>
	 <guid isPermaLink="false">news280569115</guid>
	 
</item>
<item>
     <title>Research team explains important step in the activation of T-cells in the immune system</title>
   	 <description>A team, headed by Prof. Dr. Wolfgang Schamel from the Institute of Biology III of the University of Freiburg and Prof. Dr. Balbino Alarcón from the Center for Molecular Biology Severo Ochoa of the Autonomous University of Madrid, Spain, has succeeded in explaining an important step in the activation of the so-called T-cells in the immune system. In humans and mice, T-cells are responsible for deciding whether a defense reaction should be activated to combat foreign substances. Scientists want to prevent the receptor of the T-cells (TCR) from mistakenly also identifying the body's own tissue as a foreign substance to be fended off, because this can lead to autoimmune diseases such as multiple sclerosis. In order to do so, it is first necessary to elucidate the individual steps of TCR activation. Alarcón and Schamel published their findings on the exposure of the proline-rich region, an amino acid sequence in the TCR, in the current issue of the Journal of Immunology. The American Association of Immunologists selected this publication as a highlight of the issue.</description>
     <link>http://medicalxpress.com/news/2013-02-team-important-t-cells-immune.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 07 Feb 2013 10:49:39 EST</pubDate>
	 <guid isPermaLink="false">news279456568</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/biologie_schamel_immunology_t-zellen_region_grafik_en_(wolfgang_schamel).jpg" width="90" height="90" />
</item>
<item>
     <title>Immune system can use melanoma's own proteins to kill off cancer cells</title>
   	 <description>Though a small group of proteins, the family called Ras controls a large number of cellular functions, including cell growth, differentiation, and survival. And because the protein has a hand in cellular division, mutated Ras, which can be detected in one-third of all tumors, contributes to many human cancers by allowing for the rapid growth of diseased cells.</description>
     <link>http://medicalxpress.com/news/2013-02-immune-melanoma-proteins-cancer-cells.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 04 Feb 2013 11:35:27 EST</pubDate>
	 <guid isPermaLink="false">news279200113</guid>
	 
</item>
<item>
     <title>Researchers shed light on the workings of the body's immune response</title>
   	 <description>Researchers from Queen Mary, University of London have discovered that two proteins which are believed to play a key role in controlling the body's immune response are found in lower levels in T lymphocytes from patients with multiple sclerosis (MS).</description>
     <link>http://medicalxpress.com/news/2012-12-body-immune-response.html</link>
	 <category>Immunology</category>
	 <pubDate>Wed, 12 Dec 2012 12:50:49 EST</pubDate>
	 <guid isPermaLink="false">news274539026</guid>
	 
</item>
<item>
     <title>Research suggests a new strategy to prevent or halt periodontal disease</title>
   	 <description>Periodontitis, a form of chronic gum disease that affects nearly half of the U.S. adult population, results when the bacterial community in the mouth becomes unbalanced, leading to inflammation and eventually bone loss. In its most severe form, which affects 8.5 percent of U.S. adults, periodontitis can impact systemic health.</description>
     <link>http://medicalxpress.com/news/2012-12-strategy-halt-periodontal-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Fri, 07 Dec 2012 13:20:47 EST</pubDate>
	 <guid isPermaLink="false">news274108785</guid>
	 
</item>
<item>
     <title>Study identifies a potential cause of Parkinson's disease</title>
   	 <description>Deciphering what causes the brain cell degeneration of Parkinson's disease has remained a perplexing challenge for scientists. But a team led by scientists from The Scripps Research Institute (TSRI) has pinpointed a key factor controlling damage to brain cells in a mouse model of Parkinson's disease. The discovery could lead to new targets for Parkinson's that may be useful in preventing the actual condition.</description>
     <link>http://medicalxpress.com/news/2012-11-potential-parkinson-disease.html</link>
	 <category>Parkinson's &amp; Movement disorders</category>
	 <pubDate>Mon, 19 Nov 2012 16:51:33 EST</pubDate>
	 <guid isPermaLink="false">news272566120</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/6-studyidentif.jpg" width="90" height="97" />
</item>
<item>
     <title>Researchers discover immune pathway</title>
   	 <description>Researchers from Aarhus University, Denmark, have now discovered an important mechanism behind one of our most fundamental lines of immune function. The discovery has been published in the esteemed scientific journal, The Journal of Immunology, where it has been highlighted as a top story.</description>
     <link>http://medicalxpress.com/news/2012-11-immune-pathway.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 06 Nov 2012 09:51:21 EST</pubDate>
	 <guid isPermaLink="false">news271417870</guid>
	 
</item>
<item>
     <title>Preterm labor powerhouse therapy offers promise for inflammatory diseases</title>
   	 <description>Magnesium sulfate is given to many pregnant women to treat preterm labor and preeclampsia and was recently shown to prevent cerebral palsy; however little is known about how it works. Researchers at Case Western Reserve University School of Medicine recently discovered the mechanism by which magnesium reduces the production of cytokines. Cytokines are molecules responsible for regulating inflammation; they play a key role conditions, such as diabetes, obesity, atherosclerosis, asthma, and alcoholic liver disease and cirrhosis. Although the study related to pregnancy, inflammation is the culprit of many conditions and learning more about individual's magnesium levels may help a much broader patient population.</description>
     <link>http://medicalxpress.com/news/2012-10-preterm-labor-powerhouse-therapy-inflammatory.html</link>
	 <category>Inflammatory disorders</category>
	 <pubDate>Tue, 09 Oct 2012 15:43:32 EST</pubDate>
	 <guid isPermaLink="false">news269016204</guid>
	 
</item>
<item>
     <title>Researchers identify unforeseen regulation of the anti-bacterial immune response</title>
   	 <description>New research from the laboratory of Dr. Andrea Cooper at the Trudeau Institute, just published in the European Journal of Immunology, holds promise for the improved prevention and treatment of bacterial infections and the life-threatening complications of chronic inflammation that can result from them. The publication title is &quot;Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection&quot;.</description>
     <link>http://medicalxpress.com/news/2012-08-unforeseen-anti-bacterial-immune-response.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 28 Aug 2012 12:36:46 EST</pubDate>
	 <guid isPermaLink="false">news265376195</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/trudeauresea.jpg" width="90" height="90" />
</item>
<item>
     <title>Delivery system for gene therapy may help treat arthritis</title>
   	 <description>A DNA-covered submicroscopic bead used to deliver genes or drugs directly into cells to treat disease appears to have therapeutic value just by showing up, researchers report.</description>
     <link>http://medicalxpress.com/news/2012-05-delivery-gene-therapy-arthritis.html</link>
	 <category>Immunology</category>
	 <pubDate>Tue, 15 May 2012 03:30:02 EST</pubDate>
	 <guid isPermaLink="false">news256271396</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/deliverysyst.jpg" width="90" height="84" />
</item>
<item>
     <title>Regulatory immune cell diversity tempers autoimmunity in rheumatoid arthritis</title>
   	 <description>Untangling the root cause of rheumatoid arthritis has been a difficult task for immunologists, as decades of research has pointed to multiple culprits in our immune system, with contradictory lines of evidence. Now, researchers at The Wistar Institute announce that it takes a diverse array of regulatory T cells (a specialized subset of white blood cells) to prevent the immune system from generating the tissue-specific inflammation that is a hallmark of the disease. Regulatory T cell diversity, the researchers say, provides a cumulative protective effect against rheumatoid arthritis. When that diversity is not present, it allows the immune system to attack joints.</description>
     <link>http://medicalxpress.com/news/2012-05-regulatory-immune-cell-diversity-tempers.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Tue, 08 May 2012 14:52:26 EST</pubDate>
	 <guid isPermaLink="false">news255707478</guid>
	 
</item>
<item>
     <title>New study has implications for treating and preventing cancers caused by viruses</title>
   	 <description>New research from the Trudeau Institute addresses how the human body controls gamma-herpesviruses, a class of viruses thought to cause a variety of cancers. The study, carried out in the laboratory of Dr. Marcia Blackman, awaits publication in The Journal of Immunology. Led by postdoctoral fellow Mike Freeman, with assistance from other laboratory colleagues, the study describes the role of white blood cells in controlling gamma-herpesvirus infections and has implications for the treatment and prevention of certain cancers.</description>
     <link>http://medicalxpress.com/news/2012-03-implications-cancers-viruses.html</link>
	 <category>Immunology</category>
	 <pubDate>Mon, 12 Mar 2012 17:01:15 EST</pubDate>
	 <guid isPermaLink="false">news250790469</guid>
	 
</item>
<item>
     <title>Researchers discover how vitamin D inhibits inflammation</title>
   	 <description>Researchers at National Jewish Health have discovered specific molecular and signaling events by which vitamin D inhibits inflammation. In their experiments, they showed that low levels of Vitamin D, comparable to levels found in millions of people, failed to inhibit the inflammatory cascade, while levels considered adequate did inhibit inflammatory signaling. They reported their results in the March 1, 2011, issue of The Journal of Immunology.</description>
     <link>http://medicalxpress.com/news/2012-02-vitamin-d-inhibits-inflammation.html</link>
	 <category>Immunology</category>
	 <pubDate>Thu, 23 Feb 2012 07:40:54 EST</pubDate>
	 <guid isPermaLink="false">news249205231</guid>
	 
</item>
<item>
     <title>The balancing act between protection and inflammation in MS</title>
   	 <description>Scientists have discovered a molecular mechanism that could help explain how multiple sclerosis (MS) and other autoimmune diseases can be exacerbated by the onset of an infection.</description>
     <link>http://medicalxpress.com/news/2012-02-inflammation-ms.html</link>
	 <category>Immunology</category>
	 <pubDate>Fri, 17 Feb 2012 11:16:23 EST</pubDate>
	 <guid isPermaLink="false">news248699773</guid>
	 
</item>
<item>
     <title>How unchecked alarms can spark autoimmune disease</title>
   	 <description>(Medical Xpress) -- One in five Americans suffers from autoimmune disease, in which the immune system goes off-track and attacks the body's own cells. Cornell researchers have identified a signaling mechanism in immune-system cells that may contribute to this mistake, opening the door for possible new therapies for autoimmune diseases such as lupus and arthritis.</description>
     <link>http://medicalxpress.com/news/2011-11-unchecked-alarms-autoimmune-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 29 Nov 2011 03:50:02 EST</pubDate>
	 <guid isPermaLink="false">news241760991</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/howunchecked.jpg" width="89" height="93" />
</item>
<item>
     <title>Latest discovery in the fight against tuberculosis announced</title>
   	 <description>New research from the Trudeau Institute may help in the ongoing fight against tuberculosis. Dr. Andrea Cooper's lab has discovered a connection between the development of new lymphoid tissue within the lung and protection against the disease. The new data will be published in the November 1 print issue of The Journal of Immunology (Vol. 187, Num. 10) and is available now online ahead of print.</description>
     <link>http://medicalxpress.com/news/2011-10-latest-discovery-tuberculosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 18 Oct 2011 09:37:02 EST</pubDate>
	 <guid isPermaLink="false">news238149372</guid>
	 
</item>
<item>
     <title>Peanut allergy turned off by tricking immune system</title>
   	 <description>Researchers have turned off a life-threatening allergic response to peanuts by tricking the immune system into thinking the nut proteins aren't a threat to the body, according to a new preclinical study from Northwestern Medicine. The peanut tolerance was achieved by attaching peanut proteins onto blood cells and reintroducing them to the body -- an approach that ultimately may be able to target more than one food allergy at a time.</description>
     <link>http://medicalxpress.com/news/2011-10-peanut-allergy-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 11 Oct 2011 11:49:10 EST</pubDate>
	 <guid isPermaLink="false">news237552538</guid>
	 
</item>
<item>
     <title>A safer vaccination for Alzheimer's disease?</title>
   	 <description>The research shows that in addition to the major histocompatibility complex (MHC) molecules, which present the antigen vaccine to the immune cells, genetic factors, that control some immune cells, influence the quality of response to vaccinations. The results could make it possible to prevent neuroinflammatory reactions, which are major obstacles preventing the use of the vaccination in humans. This study has just been published in the Journal of Immunology.</description>
     <link>http://medicalxpress.com/news/2011-10-safer-vaccination-alzheimer-disease.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 11 Oct 2011 11:39:18 EST</pubDate>
	 <guid isPermaLink="false">news237551936</guid>
	 
</item>
<item>
     <title>Newest cancer therapies multi-task to eliminate tumors</title>
   	 <description>Some of the newest therapies in the war on cancer remove the brakes cancer puts on the immune system, Georgia Health Sciences University researchers report.</description>
     <link>http://medicalxpress.com/news/2011-09-cancer-therapies-multi-task-tumors.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 16 Sep 2011 09:52:13 EST</pubDate>
	 <guid isPermaLink="false">news235385521</guid>
	 
</item>
<item>
     <title>Researchers overcome barrier to cancer immunotherapy</title>
   	 <description>(Medical Xpress) -- In lab studies, researchers at Virginia Commonwealth University Massey Cancer Center have effectively reprogrammed cells of the innate and adaptive immune system to overcome a key cancer defense mechanism and develop long-lasting memory to reject breast cancer cells and guard against tumor relapse.</description>
     <link>http://medicalxpress.com/news/2011-09-barrier-cancer-immunotherapy.html</link>
	 <category>Cancer</category>
	 <pubDate>Fri, 02 Sep 2011 09:26:40 EST</pubDate>
	 <guid isPermaLink="false">news234174367</guid>
	 
</item>
<item>
     <title>Research opens the possibility of temporarily reversing aging in the immune system</title>
   	 <description>Researchers funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have discovered a new mechanism controlling ageing in white blood cells. The research, published in the September issue of the Journal of Immunology, opens up the possibility of temporarily reversing the effects of ageing on immunity and could, in the future, allow for the short-term boosting of the immune systems of older people.</description>
     <link>http://medicalxpress.com/news/2011-08-possibility-temporarily-reversing-aging-immune.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 16 Aug 2011 09:22:25 EST</pubDate>
	 <guid isPermaLink="false">news232705333</guid>
	 
</item>
<item>
     <title>Researchers announce discovery in fight against sepsis</title>
   	 <description>New research from the Trudeau Institute may help to explain why anticoagulant therapies have largely failed to extend the lives of patients with sepsis. The study was led by Deyan Luo, a postdoctoral fellow in Stephen Smiley's laboratory. It shows that fibrin, a key product of the blood clotting process, is critical for host defense against Yersinia enterocolitica, a gram-negative bacterium that causes sepsis in humans and experimental mice. The new data will be published in the August 15 issue of The Journal of Immunology and is available now online ahead of print.</description>
     <link>http://medicalxpress.com/news/2011-07-discovery-sepsis.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 11 Jul 2011 12:36:24 EST</pubDate>
	 <guid isPermaLink="false">news229606573</guid>
	 
</item>
<item>
     <title>New discovery in battle against plague and bacterial pneumonias</title>
   	 <description>Researchers from the Smiley lab at the Trudeau Institute have now identified a single component of the plague causing bacterium that can be used as a vaccine. This single &quot;subunit&quot; could potentially be used to create a safer form of a T cell-stimulating plague vaccine. The new data is featured in the July issue of The Journal of Immunology.</description>
     <link>http://medicalxpress.com/news/2011-06-discovery-plague-bacterial-pneumonias.html</link>
	 <category>Medical research</category>
	 <pubDate>Mon, 27 Jun 2011 10:30:22 EST</pubDate>
	 <guid isPermaLink="false">news228389412</guid>
	 
</item>
<item>
     <title>Scientists discover way to amp up power of killer T cells</title>
   	 <description>Researchers with UCLA's Jonsson Comprehensive Cancer Center have discovered a way to amp up the power of killer T-cells, called CD8 cells, making them more functional for longer periods of time and boosting their ability to multiply and expand within the body to fight melanoma, a new study has found.</description>
     <link>http://medicalxpress.com/news/2011-05-scientists-amp-power-killer-cells.html</link>
	 <category>Medical research</category>
	 <pubDate>Tue, 10 May 2011 09:10:57 EST</pubDate>
	 <guid isPermaLink="false">news224237408</guid>
	 
</item>


</channel>
</rss>
